mbryonic megakaryopoiesis starts in the yolk sac on gestational day 7.5 as part of the primitive wave of hematopoiesis, and it continues in the fetal liver when this organ is colonized by hematopoietic progenitors between day 9.5 and 10.5, as the definitive hematopoiesis wave. We characterized the precise phenotype of embryo megakaryocytes in the liver at gestational day 11.5, identifying them as CD41 
CD42c
+ tetraploid cells that express megakaryocyte-specific transcripts and display differential traits when compared to those present in the yolk sac at the same age. In contrast to megakaryocytes from adult bone marrow, embryo megakaryocytes are CD45 -until day 13.5 of gestation, as are both the megakaryocyte progenitors and megakaryocyte/erythroid-committed progenitors. At gestational day 11.5, liver and yolk sac also contain CD41 + cells, at difference from those from bone marrow.
CD45 expression discriminates waves of embryonic megakaryocytes in the mouse
ture, platelet factor 4 (PF4), CD9, von Willebrand factor (VWF), are separated from erythroid progenitors, and closer to other myeloid progenitors expressing Flt3 and the macrophage colony-stimulating factor-1 receptor (Csf1r/CD115). 7 Clonal unilineage megakaryocyte progenitors (MKP) were defined as burst-forming unit megakaryocytes (BFU-MK) and as colony-forming unit megakaryocytes (MK- 1, 9 Other studies revealed distinct lineage potentials among erythromyeloid progenitors, 10 defining megakaryocyte/erythroid-committed progenitors (PreMegE) as Lin Embryo hematopoiesis proceeds in two phases, primitive and definitive, which are conserved among different species, including mice and humans. 11, 12 In the mouse, a primitive wave of erythromyeloid cells forms in the yolk sac (YS) at E7.5. 13, 14 At E8.5 erythromyeloid progenitors are generated in the YS and the intraembryonic paraaortic splanchnopleura/aorta-gonads-mesonephros region (PSp/AGM), the latter also containing progenitors with lymphoid activity. [15] [16] [17] Definitive HSC that are the source of all adult hematopoietic cell lineages are present in the PSp/AGM at E10. 5 . 18 The emergence of these definitive HSC in the embryo is dependent on the expression of the transcription factor RUNX1, 19 which is required for progression of CD41 + embryonic precursors into HSC. 20 The fetal liver (FL) represents the major hematopoietic organ during gestation, receiving extrinsic HSC and MPP from the YS, PSp/AGM and the placenta at E10.5. MEP involved in primitive and definitive megakaryopoiesis appear in the YS at E7.25 and at E9.5, respectively. 21, 22 RUNX1-independent diploid platelet-forming cells have been identified in the YS at E8.5/10.5. 23 Moreover, CD42c + megakaryocytes can be identified in the YS, in circulation and in the FL from E9.5 onwards, and large reticulated immature platelets circulate at E10.5. 21, 24 Embryo-derived megakaryocytes differ from those from the adult BM, as illustrated by the in vitro effects of thrombopoietin, 25 cell-intrinsic differences in vivo after transplantation 26 and the smaller size of those from YS. 22 In the FL from E10.5-E11.5 mice, megakaryocytes progressively increase in size and ploidy. 27 However, despite several reports on BMderived megakaryopoiesis published recently, the intermediate cells that appear during this process early in life, and the changes in surface phenotype, have yet to be fully defined.
We found previously that at E10.5/E11. 
Methods

Mice and embryo microsurgery and cell suspensions
BALB/c, C57BL/6 and C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6) 2Bck/J MaFIA 29 mice were maintained at the animal facilities of the Instituto de Salud Carlos III. All animal studies were approved by the Animal Health Ethics Authority from the Autonomous Government of Madrid (PROEX 080/15). Embryo microsurgery and cell suspensions were obtained as described previously 28 and in the Online Supplementary Methods.
Flow cytometry and cell purification
Cells were stained as reported elsewhere, 28 with the fluorochrome-labeled antibodies described in the Online Supplementary Methods and Online Supplementary Tables S1 and S2.
Quantitative real-time polymerase chain reaction analysis
RNA was extracted, oligo(dT)-primed cDNA samples were prepared and quantitative real-time polymerase chain reaction (RTqPCR) amplifications were performed with the primers and protocols described, 30, 31 as indicated in the Online Supplementary Methods and Online Supplementary Table S3 .
Colony-forming cell assays and cell cultures
Clonal semisolid cultures and cultures of purified cell populations were performed as indicated in the Online Supplementary Methods.
Immunofluorescence
Immunostaining was performed on cryosections from YS and embryos as indicated in the Online Supplementary Methods. The preparations were analyzed by confocal microscopy (Leica DMRD) and the images were processed with ImageJ software.
Statistical analysis
GraphPad Prism 4.0 software was used to calculate the means and standard error of the mean (SEM). Comparisons were performed with unpaired and paired Student t tests, with the χ 2 test or the Kruskal-Wallis test, to obtain the P values. Data are expressed as mean ± SEM. A P-value less than 0.05 was defined as statistically significant; statistical significance is shown as *P<0.05, **P<0.01 and ***P<0.001.
Results
Megakaryocyte lineage cells are present in hematopoietic organs and blood vessels during post-gastrulation embryo development
Co-expression of the CD41/aIIa integrin (GPIIb) and CD42c/GPIb-β chains was used to trace megakaryocytes and platelets by flow cytometry. CD41 ++ CD42c + megakaryocytes were detected from E9.5 in the YS, and in the circulating peripheral blood mononuclear cells and the P-Sp/AGM from this moment on ( Figure 1A) . Similarly, CD41 ++ CD42c + cells were found from E10.5 in the FL, although the mean fluorescence intensity (MFI) of CD41 in CD41
++
CD42c
+ megakaryocytes was weaker than that at other locations, as particularly evident in E11.5 samples ( Figure 1B ). CD41
++
CD42c
+ megakaryocytes were more abundant in the YS than in the P-Sp/AGM and FL at E10.5, and their numbers increased along gestation ( Figure 1C) . Cells in the window corresponding to platelets (low forward scatter/side scatter on a log scale) were also detected in the YS and FL from E8.5 and E10.5, respectively, and they were in the circulation from E9.5 ( Figure 1D ) as described previously. 23 Consistent with previous reports, 21 the earliest platelets were large and although their size diminished in the YS and FL as gestation progressed, those circulating remain large until E13.5 ( Figure 1E ).
Megakaryocytes in the E9.5-E11.5 mouse embryo accumulate in the fetal liver
To trace the anatomic distribution of CD41 ++ megakaryo cytes at E11.5 in the YS and embryo, immunofluorescence analyses were performed. YS preparations contained clusters of small CD41 ++ cells that may correspond to aggregated platelets, as well as individual megakaryo cytes (Figure 2A ). In the embryo proper, CD41 ++ megakaryocytes were enriched in the FL. From E10.5 to E15.5, FL CD41 ++ megakaryocytes increased in volume and enhanced the complexity of the so-called membrane demarcation system (DMS, involved in proplatelet formation), indicating maturation to megakaryo -CD45-negative megakaryopoiesis in the mouse embryo haematologica | 2019; 104(9) 
CD42c
+ megakaryocytes from E11.5 FL were tetraploid (4N or more) ( Figure 2F ). By contrast, YS CD41 ++ megakaryocytes were smaller and mostly diploid, as described for the diploid platelet-forming cells. 23 At E10.5, FL megakaryocytes displayed a less complex membrane demarcation system than the concurrent YS diploid platelet-forming cells, although the latter did not reach greater membrane demarcation system complexity at E11.5, as did those from FL ( Figure 2D ).
As we found previously, 
-cells (population #2) in these same preparations. Also, most embryo megakaryocytes from E11.5 placenta were CD45 -( Figure  3C ). From E13.5 onwards, CD41
++
CD42c
+ megakaryocytes displayed low levels of CD45, which increased at E15.5, and megakaryocytes from adult BM were CD45 + ( Figure 3C ). Accordingly, CD45 was not detected by RTqPCR in CD41 ++ CD42c + samples from the YS and FL at E11.5, while they expressed Runx1 ( Figure 3D ).
The fact that CD41 ++ CD42c + megakaryocytes were mostly CD45 -in the YS and FL until E13.5 suggested that the initial FL megakaryocytes may be derived by the homing of CD45 -megakaryocytes from the YS. The expression of selected markers by the CD41 ++
CD45
-cells present in the YS and FL between E10.5 to E11.5 (c-Kit and CD42c) (Table 1 ) indicated a maturation of these cells in the YS (the brightness of c-Kit dropped and the expression of CD42c increased) that was not so evident in the FL during the same period, and consequently at E11.5 CD41 ++
-cells in the FL showed weaker CD41 fluorescence ( Figure 1B) , and stronger c-Kit expression (Table  1 ) than those in the YS at E11.5.
Therefore, our data show that at E11.5 YS and FL megakaryocytes differ in their cell volume and ploidy. Those from YS are diploid platelet-forming cells while
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Weak CD45 expression in megakaryocyte progenitors in the E11.5 embryo
In the adult BM, all nucleated stages of megakaryocyte differentiation are CD45 + . 33 Since most megakaryocytes were CD45 -at E11.5, we wondered whether megakaryocyte lineage-committed progenitors were also CD45 -at these embryonic stages. We therefore determined the number of cells expressing CD45, and the levels of CD45, among LSK, PreMegE, MKP, CMP, GMP and CLP cells (their phenotypes are defined in Online Supplementary Table S1) in E11.5 FL cell suspensions, comparing these with cells from the liver and BM of newborn mice (postnatal day 3, PD3) and from those in the adult BM. The level of CD45 expression was weaker in E11.5 samples than in those from adult mice. Remarkably, both the frequency of cells expressing CD45 and the levels of CD45 CD45-negative megakaryopoiesis in the mouse embryo haematologica | 2019; 104 (9) 1857 + immature megakaryocytes equivalent to those from BM were present in the E11.5 embryo, we analyzed CD41/CD45 expression in cell preparations from the YS and FL. At E11. 
CD45
-cells mostly produced E-CFU progenitors and no MK-CFU ( Figure 4G ).
In summary, the expression of AChE and other surface and molecular markers, as well as clonal megakaryocyte and hematopoietic lineage differentiation assays indicated that R4/CD41 
The mean fluorescence intensity (MFI) of electronically gated CD45 -CD41 ++ cells was determined. Values are the mean ± standard error of mean and (number). The statistical significances were calculated using unpaired and paired t tests (the latter when values were obtained from the same pools of embryos). E: embryonic day; YS: yolk sac; FL: fetal liver.
In vitro megakaryocyte differentiation stages from CD45 + and CD45 -megakaryocyte lineages in the fetal liver at E11.5
In order to reproduce the steps of megakaryocyte differentiation in vitro, we used short-term liquid cultures (STLC) to trace the differentiation of cells from purified R1-R4 E11.5 FL cell suspensions defined in Figure 4A, Figure 5B ). DNA content analysis of the CD41
++
CD42c
++ megakaryocytes growing in the STLC from FL R2-R4 cell subsets showed that they accumulated in the 8N stage although the megakaryocytes generated in R4/CD41 
CD45
++ STLC were not elongated nor did they present a P-MK morphology ( Figure 5D ). Therefore, during the differentiation to CD41 ++
-megakaryocytes from CD41 -
++ and CD41 + CD45 + cells, a reduction of CD45 levels occurred in conjunction with an increase of CD42c ( Figure 5F ). Although we found a reduction in the CD45 transcript levels from CD41 + CD45
+ cells in STLC (Online Supplementary Figure S5B) Figure S4D-E) allowed the growth of large cells and P-MK displaying large proplatelets after 96 h, reaching ploidy stages up to 64N. The megakaryocytes (CD41 ++ CD42c + ) in these cultures were consistently haematologica | 2019; 104(9) 
CD42c
+ cells, although at the times of analysis they did not undergo great morphological CD45-negative megakaryopoiesis in the mouse embryo haematologica | 2019; 104 (9) 1861 ++ cells is shown. The box inside (R5) shows the CD45 + CD11b + cell population that is analyzed for the expression of CD41 in the bottom left contour plot, identifying cells expressing or not CD41 (R6 and R7 boxes inside the plot). The purified populations of R5/CD45 + CD11b + , R6/CD45 + CD11b + CD41 -and R7/CD45 + CD11b + CD41 + cells were cultured in short-term liquid cultures (STLC) for 48 h, recovered and stained as in Figure 5B . Representative contour plots (upper right) of the cells recovered for the STLC performed with R5/CD45 + CD11b + purified cells are shown. The boxes in the plots indicate the cell subsets analyzed in the bottom graph, which displays the frequency of the cells grown in STLC from R5, R6 and R7 cells. The data are the means ± standard error of mean (SEM) (n=3). (B) Cell suspensions were prepared from bone marrow (BM) from 2-month old C57BL/6 and MaFIA mice, and were stained with anti-CD45-PE-Cy7, anti-CD41-PE, anti-CD9-APC and CD115-BV605. The C57BL/6 preparations also included an anti-CD42c-FITC. Fluorescence-minus-one (FMO) isotype controls for the CD115 and the CD42c antibodies were included. Representative contour plots display the CD41/CD42c/CD115 (upper plot and histogram) or the EGFP/CD41 (bottom plot) signals corresponding to CD9 +++ cells (left plot) from C57BL/6 and MaFIA mice, respectively. The histogram shows the CD115 signal (filled in gray) displayed by CD9 ++ CD41 ++ CD42c + BM megakaryocytes from C57BL/6 mice. The corresponding FMO isotype control is overlaid (dotted line). Boxes inside the bottom plot indicate the EGFP -and EGFP + CD9 +++ CD41 ++ cells that were purified by cell sorting and analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) for the expression of NE-F2 and VWF transcripts as in Figure 4E Figure 6A and Online Supplementary Figures S3  and S5D ). We reasoned that CD45 ++ cells could be a heterogeneous population, containing cells able to differentiate into megakaryocytes. Indeed, low levels of CD41 were expressed in CD45
++
CD11b
+ cells ( Figure 6A ). We postulated that these CD41 Figure S5D) .
To confirm these results we used samples from MaFIA transgenic mice, which allow tracking of cells expressing the macrophage-specific promoter for Csf1r/CD115. 29 We analyzed BM preparations from adult mice, in which megakaryocytes were identified as Ter119 -CD45 + CD9 ++ CD41 ++ CD42c + ( Figure 6B ). BM megakaryocytes from C57BL/6 mice expressed CD115 (26% ± 5.4 %; n=4). Accordingly, around 30% ± 3. 
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haematologica | 2019; 104(9) Figure 6C ) differentiate in STLC (data in Figure 5B and 5D) towards CD45-embryonic-type megakaryocytes (EMK) (middle left plot) and to CD45 + adult-type megakaryocytes (AMK) (middle-right plot). (C) Cultures from CD41 +/-CD45 ++ CD42c -CD11b + CD115 + embryonic progenitors (data in Figure 6E ) give rise to CD11b 
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Discussion
The morphological, functional and molecular changes that take place in the differentiation of megakaryocytes have been assessed here using bulk in vitro cultures of megakaryocyte-committed progenitors from the E11. 5 ++ megakaryocytes are negative, until E13.5, for the leukocyte common CD45 antigen, a large transmembrane glycoprotein expressed on the surface of all hematopoietic cells and their precursors, except mature erythrocytes and platelets. 33, 35, 36 CD45 accounts for up to 10% of lymphocyte cell surface proteins and is involved in the dephosphorylation of the regulatory tyrosine of Src family kinases, negatively modulating cell signaling. 33, 35, 36 The CD45 protein sets the threshold for signal transduction, and CD45 deficiency produces developmental defects and extended phosphorylation of the JAK/STAT cascade. 37 The absence of CD45 or diminished levels of this protein have been associated with a hyperadhesive phenotype and impairment of progenitor mobilization from the BM. 38, 39 It could be that the low expression of CD45 may favor the observed accumulation of megakaryocytes in FL at E11.5, together with interactions through integrin receptors that are expressed highly by megakaryocytes.
We used CD41 expression to trace megakaryocytes, since CD41 is expressed strongly by cells of the megakaryo cyte lineage, including platelets, in the adult mouse. 40 CD41 was defined as a marker for the early stages of primitive and definitive hematopoiesis in the mouse embryo, 13 and as a marker of HSC in mice and zebrafish, 41, 42 tracing the divergence of definitive hematopoiesis from endothelial cells in mouse c-Kit + progenitors. 40 ,43 CD41 ++ CD45 -megakaryocytes are found in the YS and embryo (P-Sp/AGM, FL) from E9.5 and in the circulating blood, as also reported by others. 23 Interestingly, E11.5, PreMegE and MKP also display less CD45 than those from newborn and adult BM, whereas CD45 levels appear to be similar in other lineage progenitors, revealing a linkage of the CD45 -/dim trait to embryo erythroid/megakaryocyte-lineage cells. Since CD41 ++ megakaryocytes remain CD45 -until E13.5 in the FL, it is tempting to speculate that CD45 -EMK may correspond to the primitive wave of megakaryopoiesis generating CD41 + CD42c + Runx1 -diploid platelet-forming cells described in the YS at E10.5. 23 The progression of primitive HSC to definitive HSC is dependent on RUNX1. 20 At E11.5 RUNX1-deficient mice have primitive erythrocytes but lack hematopoietic cells in FL and identifiable platelets in blood. 44 They also lack definitive HSC and CD45 + cells, and have very few CD41 ++
CD45
-cells. 20 It would thus be conceivable that CD45 -Runx1 + megakaryocytes present in the FL at E11.5 belong to the definitive wave of megakaryo poiesis. However, RUNX1 is essential for megakaryocyte maturation in the adult BM. 45 Therefore, the fact that EMK in the E11.5 FL are Runx1 + , and that many of them are tetraploid cells with larger size than those in the contemporaneous YS, may indicate that the local environment in the FL provides conditions allowing maturation of primitive wave CD45 -megakaryocytes. It has been described that megakaryocytes require MPL in order to reach >8N maturation stages after E14.5. 24 At E11.5, after 2 days in culture, the cell subpopulations isolated from FL produced mostly megakaryocytes with 8N ploidy, which may represent the in vitro differentiation of MPL-independent megakaryocytes. Also, at E11.5 FL R4/CD41 ++ CD45
-megakaryocytes express the transcription factors NF-E2 and Fli1, in agreement with the findings on a megakaryocyte transcription factor core for YS diploid platelet-forming cells at E10.5 and for FL megakaryocytes at E13.5. 24 In the FL, CD41 and CD45 expression define several cell subsets at E11. 5 -cells have a more immature phenotype than the aforementioned populations. The phenotypic data and the gene expression profile ex vivo, as well as in vitro studies of these purified populations, prompt us to propose two major pathways of megakaryocyte differentiation operating in the E11.5 FL ( 
CD42c
+ EMK arise. Therefore, CD45 diminishes when the levels of CD41 of these increase and they acquire CD42c to become EMK. The first pathway is common before E13.5 but becomes rare after E15.5, and it is currently unknown whether it is even retained at low levels in the BM, while the reverse applies to the CD45 -derived pathway, although in this case CD45 is retained in BM CD41
++
CD42c
+ megakaryocytes. Moreover, our data reveal the involvement of Csf1r-expressing cells in adult BM CD45 + megakaryopoiesis, which may represent a third pathway of megakaryopoiesis ( Figure 7C ), minor or absent in the embryo, and opens the issue of the generation of CD41 ++ megakaryocytes from CD45 ++ CD115 -expressing cells in the adult. Csf1r/CD115 is considered a mature monocytic differentiation receptor, 46 but besides the high expression of Csf1r in monocytes, macrophages, osteoclasts and myeloid dendritic cells, it is also expressed at low levels on HSC, CMP and CLP, as well as among several non-hematopoietic embryonic cells. 47 More work is needed to clarify the differential contribution of these CD45 ++ CD11b + CD115 + cells to adult and embryo megakaryopoiesis and its relevance.
Embryo-fetal-derived megakaryocytes engraft poorly into adult mice and produce low number of platelets. 48, 49 It is presently unknown whether the different subsets of megakaryocyte progenitors identified in the embryo may give rise to functional or immature platelets in vivo, but they may represent new tools to uncover the mechanisms underlying the maturation of the membrane demarcation system assembly machinery that yields platelets, similarly as the recently described mechanisms by which BM megakaryocytes sense extracellular matrix rigidity to release platelets. 50 In summary, we present a number of findings proving that embryo megakaryocytes are hematopoietic CD45
-nucleated cells that are produced from CD45 -and CD45 + progenitor cells, findings that may be extended to human cord blood samples in order to probe the existence of a human CD45 -megakaryocyte counterpart. These issues have relevant implications for understanding aberrant megakaryopoiesis processes and megakaryocyte-derived tumors, and also represent a tool CD45-negative megakaryopoiesis in the mouse embryo haematologica | 2019; 104 (9) that may provide clues to improve megakaryocyte reconstitution by using cord blood-derived progenitors for transplantation and for designing better conditions to increase platelet production to treat thrombocytopenic pathologies. 
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